Prodotti competitors / Area HIV
mRNA vaccine candidates for HIV enter Phase I trial - Will mRNA vaccines one day protect against HIV? Three investigational mRNA vaccines, all designed to combat HIV, have entered Phase I testing
![Immagine News](/media/l4el5htd/cat-2.jpg?anchor=center&mode=crop&width=722&height=442)
The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), has begun a Phase I trial evaluating three experimental messenger RNA (mRNA) HIV vaccines. These vaccines are based on the same technology as the COVID-19 vaccines developed by Pfizer/BioNTech and Moderna.
More details at the following link: https://www.europeanpharmaceuticalreview.com/news/169298/mrna-vaccine-candidates-for-hiv-enter-phase-i-trial/
Grazie per il tuo feedback!